Yahoo Web Search

Search results

  1. Jun 27, 2024 · The use of scaled-down bioreactors could also aid process optimisation studies, including for different cell therapy products,” said Michael Birnbaum, Co-Lead Principal Investigator at SMART CAMP, Associate Professor of Biological Engineering at MIT, and a co-corresponding author of the paper.

  2. Jun 20, 2024 · Michael Birnbaum is a national security reporter for The Washington Post, covering the State Department and diplomacy. He previously served in Europe for more than a decade as the...

    • Michael Birnbaum1
    • Michael Birnbaum2
    • Michael Birnbaum3
    • Michael Birnbaum4
    • Michael Birnbaum5
  3. Jun 28, 2024 · MIT Associate Professor Michael Birnbaum works on tools that can be used to study huge numbers of interactions between T cells and antigens, in hopes to learning more about how immune cells recognize their targets.

  4. Jun 28, 2024 · The use of scaled-down bioreactors could also aid process optimisation studies, including for different cell therapy products,” said Michael Birnbaum, Co-Lead Principal Investigator at SMART CAMP, Associate Professor of Biological Engineering at MIT, and a co-corresponding author of the paper.

  5. Jun 27, 2024 · The use of scaled-down bioreactors could also aid process optimisation studies, including for different cell therapy products,” said Michael Birnbaum, Co-Lead Principal Investigator at SMART...

  6. Jun 26, 2024 · A butterfly’s wing is covered in hundreds of thousands of tiny scales like miniature shingles on a paper-thin roof. A single scale is as small as a speck of dust yet surprisingly complex, with a corrugated surface of ridges that help to wick away water, manage heat, and reflect light to give a butterfly its signature shimmer.

  7. 5 days ago · In this interview, we discuss the MATCHMAKER project with team lead Michael Birnbaum (Massachusetts Institute of Technology, MIT, MA, USA) to uncover how they’re seeking to better understand and predict how T cells recognize tumors, paving the way for personalized immunotherapies.